SCHEMBL5164151

SCHEMBL5164151

Cc1nc(N(C)Cc2ccccc2)sc1C(=C=O)CN(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
NPC1 O15118 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 3/20 0.41
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165104 0.81
SCHEMBL5164158 0.80 NPC1 (0.58) ADORA2AADORA1NPC1KMT2ARAB9A
SCHEMBL5161599 0.79 ALDH1A1 (0.35) ALDH1A1HPGD
SCHEMBL5162743 0.76 NPC1 (0.67) ADORA2AADORA1NPC1KMT2ARAB9A
SCHEMBL5164166 0.76 RAB9A (0.37) NPC1KMT2ARAB9AMAPTALDH1A1
SCHEMBL5159325 0.75 RAB9A (0.56) NPC1KMT2ARAB9AMAPTALDH1A1
SCHEMBL5159248 0.74 PTGS2 (0.37) NPC1KMT2ARAB9AMAPTALDH1A1
SCHEMBL4159233 0.74 ALDH1A1 (0.65) ADORA2AADORA1NPC1KMT2ARAB9A
SCHEMBL5159310 0.74 SIGLEC9 (0.37) NPC1ALDH1A1LMNAKDM4EPOLB
SCHEMBL5162589 0.71 CRHR1 (0.34) NPC1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756098-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Cyclacel Limited (GB) 2007-02-28 EP disclosed
WO-2005116025-A2 2-SUBSTITUTED-4-HETEROARYL-PYRIMIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISORDERS CYCLACEL LIMITED (GB) 2005-12-08 WO disclosed